Zevra Therapeutics (ZVRA) Change in Inventory (2022 - 2026)

Zevra Therapeutics (ZVRA) has 5 years of Change in Inventory data on file, last reported at $185000.0 in Q1 2026.

• Quarterly Change in Inventory fell 9.76% year-over-year to $185000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 80.21% YoY) and the FY2025 annual result came in at $1.3 million, down 85.29% from the prior year.
• Change in Inventory eased to $185000.0 in Q1 2026, from $525000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $4.7 million in Q4 2024 to a low of -$241000.0 in Q3 2022.
• A 5-year average of $625687.5 and a median of $189500.0 in 2025 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory tumbled 112.03% — and 2024, when it surged 29568.75%.
• Tracing ZVRA's Change in Inventory over 5 years: stood at $133000.0 in 2022, then plunged by 112.03% to -$16000.0 in 2023, then surged by 29568.75% to $4.7 million in 2024, then slumped by 88.87% to $525000.0 in 2025, then plunged by 64.76% to $185000.0 in 2026.
• The last three Change in Inventory figures came in at $185000.0 (Q1 2026), $525000.0 (Q4 2025), and $194000.0 (Q3 2025), per Business Quant data.